Expression of HIV-1 nefin yeast causes membrane perturbation and release of the myristylated Nef protein

Journal of Biomedical Science

Volumn 5, Issue 3, 1998, Pages 203-210

  Macreadie, Ian G ^a   Fernley, Ross ^a   Castelli, Laura A ^a   Lucantoni, Anna ^a   White, Jacinta ^a   Azad, A ^a  

^a CSIRO   (Australia)

Author keywords

Acquired immunodeficiency syndrome; Human immunodeficiency virus; Membrane permeabilisation; Myristylation; Nef protein; Saccharomyces cerevisiae; Yeast

Indexed keywords

NEF PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; MYRISTYLATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SACCHAROMYCES CEREVISIAE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE VIRUS L-A (L1);

EID: 0031809428     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253470     Document Type: Article

References (45)

1. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious clone. J Virol 59: 284-291;1986.
2. Allan JS, Coligan JE, Lee T-H, McLane MF, Kanki PJ, Groopman JE, Essex M, A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230: 810-813;1985.
3. Azad AA, Failla P, Lucantoni A, Bentley J, Mardon C, Wolfe A, Fuller K, Hewish D, Sengupta S, Sankovich S, Grgacic E, McPhee D, Macreadie I. Large-scale production and characterization of recombinant human immuno deficiency virus type 1 Nef. J Gen Virol 75: 651-655;1994.
4. Barnham KJ, Monks SA, Hinds MG, Azad AA, Norton RS. Solution structure of a polypeptide from the N terminus of the HIV protein Nef. Biochemistry 36:5970-5980;1997.
5. Benichou S, Bomsel M, Bodeus M, Durand H, Doute M, Letourneur F, Camonis J, Benarous R. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem 269:30073-30076;1994.
6. Bodeus M, Marie-Cardine A, Bougeret C, Ramos-Morales F, Benarous R. In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/ threonine protein kinase. J Gen Virol 76:1337- 1344;1995.
7. Bukovsky AA, Dorfman T, Weimann A, Gottlinger HG. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J Virol 71:1013-1018; 1997.
8. Coates K, Cooke SJ, Mann DA, Harris MPG. Protein kinase C-mediated phosphorylation of HIV-1 nef in human cell lines. J Biol Chem 272:12289-12294;1997.
9. Curtain CC, Separovic F, Rivett D, Kirkpatrick A, Waring AJ, Gordon LM, Azad AA, Fusogenic activity of amino-terminal region of HIV type 1 Nef protein. AIDS Res Hum Retroviruses 10:1231-1240;1994
10. Curtain CC, Lowe MG, Arunagiri CK, Mobley PW, Macreadie IG, Azad AA. Cytolytic activity of amino-terminal region of HIV type 1 Nef protein. AIDS Res Hum Retroviruses 14: 1213-1220;1997.
11. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee D, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988- 991;1995
12. Fermin CD, Garry RF. Membrane alterations linked to early interactions of HIV with the cell surface. Virology 191:941-946;1992.
13. Franchini G, Robert-Guroff M, Ghrayeb J, Chang NT, Wong-Staal F. Cytoplasmic localization of the HTLV-III 3′ orf protein in cultured T cells. Virology 155:593-599;1986.
14. Foti M, Mangasarian A, Piguet V, Lew DP, Krause K-H, Trono D, Carpentier J-L. Nef-mediated clathrin-coated pit formation. J Cell Biol 139:37-47;1997.
15. Fujii Y, Nishino Y, Nakaya T, Tokunaga K, Ikuta K. Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells. Vaccine 11:1240-1246;1993.
16. Fujii Y, Otake K, Fujita Y, Yamamoto N, Nagai Y, Tashiro M, Adachi A. Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface. FEBS Lett 395:257-261;1996.
17. Fujii Y, Otake K, Tashiro M, Adachi A. In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4+ T cells without MHC restriction. J Gen Virol 77:2943-2951;1996.
18. Geleziunas R, Miller MD, Greene WC. Unravelling the function of HIV type 1 Nef. AIDS Res Hum Retroviruses 12:1579-1582;1996.
19. Greenway A, McPhee D. Nef - the Machiavelli of cellular activation. Res Virol 148:58-64; 1997.
20. Guy B, Kieny MP, Riviere Y, Le Peuch C, Dott K, Girad M, Montagnier L, Lecocq J-P. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330:266-269;1987.
21. Guy B, Rivière Y, Dott K, Regnault A, Kieny MP. Mutational analysis of the HIV Nef protein. Virology 176:413-425;1990.
22. Hammes SR, Dixon EP, Malim MH, Cullen BR, Greene WC. Nef protein of human immunodeficiency virus type 1: Evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci USA 86:9549-9553;1989.
23. Harris M. From negative factor to a critical role in virus pathogenesis: The changing fortunes of Nef. J Gen Virol 77:2379-2392;1996.
24. Hayakawa T, Miyazaki T, Misumi Y, Kobayashi M, Fujisawa Y. Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor. Pr53gag, in yeast. Gene 119: 273-277;1992.
25. Kaminchik J, Bashan N, Itach A, Sarver N, Gorecki M, Panet A. Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells. J Virol 65:583-588;1991.
26. Kaminchik J, Margalit R, Yaish S, Drummer H, Amit B, Sarver N, Gorecki M, Panet A. Cellular distribution of HIV type 1 Nef protein: Identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Res Hum Retroviruses 10:1003-1010;1994.
27. Kestler HW III, Ringler DJ, Mon K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662;1991.
28. Kienzle N, Bachmann M, Muller WE, Muller- Lantzsch N. Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells. Arch Virol 124:123-132;1992.
29. Kienzle N, Enders M, Buck M, Siakkou H, Jahn S, Petzold G, Schneweis KE, Bachmann M, Muller WE, Muller-Lantzsch N. Expression of the HIV-1 Nef protein in the baculovirus system: Investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef. Arch Virol 126:293-301;1992.
30. Kirchoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: Absence of intact nef sequences in a long-term survivor with progressive HIV-1 infection. N Engl J Med 332:228-232;1995.
31. Kohleisen B, Neumann M, Herrmann R, Brack-Werner R, Krohn KJE, Ovod V, Ranki A, Erfle V. Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS 6:1427-1436;1992.
32. Luo T, Foster JL, Garcia JV. Molecular determinants of Nef function. J Biomed Sci 4:132- 138;1997.
33. Macreadie IG, Ward AC, Failla P, Grgacic E, McPhee D, Azad AA. Expression of HIV-1 nef in yeast: The 27 kDa Nef protein is myristylated and fractionates with the nucleus. Yeast 9:565-573;1993.
34. Macreadie IG, Castelli LA, Failla P, Azad AA. Yeast-derived HIV-1 Nef protein lacks G-protein activities. Mol Biol (Life Sci Adv)12:99- 105;1993.
35. Macreadie IG, Castelli LA, Lucantoni A, Azad AA. Stress- and sequence-dependent release into the culture medium of HIV-1 Nef produced in Saccharomyces cerevisiae. Gene 162: 239-243;1995.
36. Macreadie IG, Lowe MG, Curtain CC, Hewish DR, Azad AA. Cytotoxicity resulting from addition of HIV-1 Nef N-terminal peptides to yeast and bacterial cells. Biochem Biophys Res Commun 232:707-711;1997.
37. Matsuura Y, Maekawa M, Hattori S, Ikegami N, Hayashi A, Yamazaki S, Morita C, Takebe Y. Purification and characterization of human immunodeficiency virus type 1 Nef gene product expressed by a recombinant baculovirus. Virology 184:580-586;1991.
38. McKimm-Breschkin JL. The use of tetramethylbenzidine for solid phase immunoassays. J Immunol Methods 135:277-280;1990.
39. Ovod V, Lagerstedt A, Ranki A, Gombert FO, Spohn R, Tahtinen M, Jung G, Krohn KJE. Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 6: 25-34;1992.
40. Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol 70: 4283-4290;1996.
41. Sanfridson A, Hester S, Doyle C. Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. Proc Natl Acad Sci USA 94:873-878;1997.
42. Sawai ET, Baur AS, Peterlin BM, Levy JA, Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem 270:15307- 15314;1995.
43. Welker R, Kottler H, Kalbitzer HR, Krausslich HG. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219:228-236;1996.
44. Wiskerchen M, Cheng-Mayer C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology 224: 292-301;1996.
45. Yu G, Felsted RL. Effect of myristylation on p27nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187: 46-55;1992.